163 related articles for article (PubMed ID: 34320651)
21. Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes.
Koca E; Kuzan TY; Dizdar O; Babacan T; Sahin I; Ararat E; Altundag K
Med Oncol; 2013; 30(3):615. PubMed ID: 23729267
[TBL] [Abstract][Full Text] [Related]
22. Significance of axillary lymph node extranodal soft tissue extension and indications for postmastectomy irradiation.
Mignano JE; Zahurak ML; Chakravarthy A; Piantadosi S; Dooley WC; Gage I
Cancer; 1999 Oct; 86(7):1258-62. PubMed ID: 10506712
[TBL] [Abstract][Full Text] [Related]
23. Cardiac and lung complication probabilities after breast cancer irradiation.
Hurkmans CW; Borger JH; Bos LJ; van der Horst A; Pieters BR; Lebesque JV; Mijnheer BJ
Radiother Oncol; 2000 May; 55(2):145-51. PubMed ID: 10799726
[TBL] [Abstract][Full Text] [Related]
24. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.
Grills IS; Kestin LL; Goldstein N; Mitchell C; Martinez A; Ingold J; Vicini FA
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):658-70. PubMed ID: 12788171
[TBL] [Abstract][Full Text] [Related]
26. Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer.
Kong AL; Tereffe W; Hunt KK; Yi M; Kang T; Weatherspoon K; Mittendorf EA; Bedrosian I; Hwang RF; Babiera GV; Buchholz TA; Meric-Bernstam F
Cancer; 2012 Dec; 118(24):6287-96. PubMed ID: 22648744
[TBL] [Abstract][Full Text] [Related]
27. A retrospective analysis on metastatic rate of the internal mammary lymph node and its clinical significance in adjuvant radiotherapy of breast cancer patients.
Li L; Zhang H; Wang L; Xie C; Zhou Y; Zhong Y
BMC Cancer; 2020 Feb; 20(1):153. PubMed ID: 32093638
[TBL] [Abstract][Full Text] [Related]
28. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist?
Freedman GM; Fowble BL; Nicolaou N; Sigurdson ER; Torosian MH; Boraas MC; Hoffman JP
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):805-14. PubMed ID: 10705000
[TBL] [Abstract][Full Text] [Related]
29. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
Krag DN; Anderson SJ; Julian TB; Brown AM; Harlow SP; Costantino JP; Ashikaga T; Weaver DL; Mamounas EP; Jalovec LM; Frazier TG; Noyes RD; Robidoux A; Scarth HM; Wolmark N
Lancet Oncol; 2010 Oct; 11(10):927-33. PubMed ID: 20863759
[TBL] [Abstract][Full Text] [Related]
30. Planning of the internal mammary field based on lymphoscintigraphy localization before postoperative radiotherapy of breast cancer.
Lotayef MM; Barsoum MS; Zaki OE; Nasr MA; Abdel Aziz RA; Koteb M; Radwan A
J Egypt Natl Canc Inst; 2005 Sep; 17(3):203-10. PubMed ID: 16799658
[TBL] [Abstract][Full Text] [Related]
31. Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer.
Halverson KJ; Taylor ME; Perez CA; Garcia DM; Myerson R; Philpott G; Levy J; Simpson JR; Tucker G; Rush C
Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):593-9. PubMed ID: 8330987
[TBL] [Abstract][Full Text] [Related]
32. Cross-sectional imaging to evaluate the extent of regional nodal disease in breast cancer patients undergoing neoadjuvant systemic therapy.
Anderson TL; Glazebrook KN; Murphy BL; Viers LD; Hieken TJ
Eur J Radiol; 2017 Apr; 89():163-168. PubMed ID: 28267534
[TBL] [Abstract][Full Text] [Related]
33. Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925).
Matzinger O; Heimsoth I; Poortmans P; Collette L; Struikmans H; Van Den Bogaert W; Fourquet A; Bartelink H; Ataman F; Gulyban A; Pierart M; Van Tienhoven G;
Acta Oncol; 2010; 49(1):24-34. PubMed ID: 20100142
[TBL] [Abstract][Full Text] [Related]
34. Radiotherapy of MRI-detected involved internal mammary lymph nodes in breast cancer.
Sachdev S; Goodman CR; Neuschler E; Kalakota K; Cutright D; Donnelly ED; Hayes JP; Prescott AE; Mirabelli G; Strauss JB
Radiat Oncol; 2017 Dec; 12(1):199. PubMed ID: 29258542
[TBL] [Abstract][Full Text] [Related]
35. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Galimberti V; Cole BF; Viale G; Veronesi P; Vicini E; Intra M; Mazzarol G; Massarut S; Zgajnar J; Taffurelli M; Littlejohn D; Knauer M; Tondini C; Di Leo A; Colleoni M; Regan MM; Coates AS; Gelber RD; Goldhirsch A;
Lancet Oncol; 2018 Oct; 19(10):1385-1393. PubMed ID: 30196031
[TBL] [Abstract][Full Text] [Related]
36. Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer.
Kuerer HM; Newman LA; Fornage BD; Dhingra K; Hunt KK; Buzdar AU; Ames FC; Ross MI; Feig BW; Hortobagyi GN; Singletary SE
Ann Surg Oncol; 1998 Dec; 5(8):673-80. PubMed ID: 9869512
[TBL] [Abstract][Full Text] [Related]
37. Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.
Gingras I; Holmes E; De Azambuja E; Nguyen DH; Izquierdo M; Anne Zujewski J; Inbar M; Naume B; Tomasello G; Gralow JR; Wolff AC; Harris L; Gnant M; Moreno-Aspitia A; Piccart MJ; Azim HA
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376188
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological features of breast cancer patients with internal mammary and/or supraclavicular lymph node recurrence without distant metastasis.
Inari H; Teruya N; Kishi M; Horii R; Akiyama F; Takahashi S; Ito Y; Ueno T; Iwase T; Ohno S
BMC Cancer; 2020 Sep; 20(1):932. PubMed ID: 32993560
[TBL] [Abstract][Full Text] [Related]
39. Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial.
Henke G; Knauer M; Ribi K; Hayoz S; Gérard MA; Ruhstaller T; Zwahlen DR; Muenst S; Ackerknecht M; Hawle H; Fitzal F; Gnant M; Mátrai Z; Ballardini B; Gyr A; Kurzeder C; Weber WP
Trials; 2018 Dec; 19(1):667. PubMed ID: 30514362
[TBL] [Abstract][Full Text] [Related]
40. Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management.
Greco M; Crippa F; Agresti R; Seregni E; Gerali A; Giovanazzi R; Micheli A; Asero S; Ferraris C; Gennaro M; Bombardieri E; Cascinelli N
J Natl Cancer Inst; 2001 Apr; 93(8):630-5. PubMed ID: 11309439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
